3 Stocks Energizing Investors After Earnings

Abbott Laboratories (NYSE:ABT) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 6.98% to $0.46 in the quarter versus EPS of $0.43 in the year-earlier quarter. Revenue Decreased 44.47% to $5.45 billion from the year-earlier quarter.

Abbott Laboratories reported adjusted EPS income of $0.46 per share. By that measure, the company beat the mean analyst estimate of $0.44. It missed the average revenue estimate of $5.52 billion.

ABT

Novartis AG (NYSE:NVS) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased 5.8% to $1.3 in the quarter versus EPS of $1.38 in the year-earlier quarter. Revenue Decreased 0.36% to $14.49 billion from the year-earlier quarter.

Novartis AG reported adjusted EPS income of $1.3 per share. By that measure, the company beat the mean analyst estimate of $1.29. It beat the average revenue estimate of $14.39 billion.

NVS

Johnson & Johnson (NYSE:JNJ) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 13.85% to $1.48 in the quarter versus EPS of $1.30 in the year-earlier quarter. Revenue Rose 8.51% to $17.88 billion from the year-earlier quarter.

Johnson & Johnson reported adjusted EPS income of $1.48 per share. By that measure, the company beat the mean analyst estimate of $1.39. It beat the average revenue estimate of $17.71 billion.

JNJ

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.